Benzinga | May 5, 2021 04:51PM EDT

Tandem Diabetes Care Q1 EPS $(0.08) Beats $(0.16) Estimate, Sales $141.04M Beat $121.96M Estimate

Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.16) by 50 percent. This is a 68 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $141.04 million which beat the analyst consensus estimate of $121.96 million by 15.64 percent. This is a 44.02 percent increase over sales of $97.93 million the same period last year.